• Publications
  • Influence
Cardiovascular and noncardiovascular mortality among patients starting dialysis.
CONTEXT Cardiovascular mortality is considered the main cause of death in patients receiving dialysis and is 10 to 20 times higher in such patients than in the general population. OBJECTIVE ToExpand
  • 482
  • 15
  • Open Access
CKD Prevalence Varies across the European General Population.
CKD prevalence estimation is central to CKD management and prevention planning at the population level. This study estimated CKD prevalence in the European adult general population and investigatedExpand
  • 225
  • 15
Renal replacement therapy in children: data from 12 registries in Europe
In June 2000 the ERA-EDTA Registry office moved to Amsterdam and started collecting core data on renal replacement therapy (RRT) entirely through national and regional registries. This paper reportsExpand
  • 129
  • 13
Sample size calculations: basic principles and common pitfalls.
One of the most common requests that statisticians get from investigators are sample size calculations or sample size justifications. The sample size is the number of patients or other experimentalExpand
  • 214
  • 11
  • Open Access
Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries.
BACKGROUND In June 2000 a new ERA-EDTA Registry Office was opened in Amsterdam. This Registry will only collect core data on renal replacement therapy (RRT) through national and regional registries.Expand
  • 307
  • 10
Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000).
BACKGROUND There is concern about the rising prevalence of type 2 diabetes mellitus and of the resultant nephropathy. This study uses data from the European Renal Association-European Dialysis andExpand
  • 163
  • 10
Physical symptoms and quality of life in patients on chronic dialysis: results of The Netherlands Cooperative Study on Adequacy of Dialysis (NECOSAD)
BACKGROUND So far, little attention has been paid to the value of dialysis adequacy for patients' quality of life (QL). Therefore we studied the impact of demographic, clinical, and dialysisExpand
  • 213
  • 9
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry.
BACKGROUND Autosomal dominant polycystic kidney disease (ADPKD) is the fourth most common renal disease requiring renal replacement therapy (RRT). Still, there are few epidemiological data on theExpand
  • 128
  • 9
  • Open Access
Quality of life in patients on chronic dialysis: Self-assessment 3 months after the start of treatment☆
The aim of the present multicenter study was to assess quality of life of Dutch dialysis patients 3 months after the start of chronic dialysis treatment. The quality of life was compared with theExpand
  • 327
  • 8
The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in The Netherlands.
BACKGROUND Patients with end-stage renal disease (ESRD) who are about to start long-term dialysis therapy are faced with the question of modality choice. The aim of the current study is to determineExpand
  • 240
  • 8